HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.
This report aims to provide a comprehensive presentation of the global market for HIV Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Drugs. This report contains market size and forecasts of HIV Drugs in global, including the following market information:
Global HIV Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global HIV Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five HIV Drugs companies in 2022 (%)
The global HIV Drugs market was valued at US$ 24060 million in 2022 and is projected to reach US$ 27490 million by 2029, at a CAGR of 1.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
One of the primary factors catalyzing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments. Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.
We surveyed the HIV Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HIV Drugs Market Segment Percentages, by Type, 2022 (%)
- Multi-Class Combination Products
- Nucleoside Reverse Transcriptase Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Fusion Inhibitors
- Entry Inhibitors - CCR5 Co-Receptor Antagonist
- HIV Integrase Strand Transfer Inhibitors
Global HIV Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HIV Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global HIV Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HIV Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies HIV Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies HIV Drugs revenues share in global market, 2022 (%)
- Key companies HIV Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies HIV Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Gilead Sciences
- GlaxoSmithKline
- Johnson & Johnson
- Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of HIV Drugs, market overview.
Chapter 2: Global HIV Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of HIV Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HIV Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global HIV Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HIV Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Drugs Overall Market Size
2.1 Global HIV Drugs Market Size: 2022 VS 2029
2.2 Global HIV Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global HIV Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top HIV Drugs Players in Global Market
3.2 Top Global HIV Drugs Companies Ranked by Revenue
3.3 Global HIV Drugs Revenue by Companies
3.4 Global HIV Drugs Sales by Companies
3.5 Global HIV Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 HIV Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers HIV Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 HIV Drugs Players in Global Market
3.8.1 List of Global Tier 1 HIV Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 HIV Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global HIV Drugs Market Size Markets, 2022 & 2029
4.1.2 Multi-Class Combination Products
4.1.3 Nucleoside Reverse Transcriptase Inhibitors
4.1.4 Non-Nucleoside Reverse Transcriptase Inhibitors
4.1.5 Protease Inhibitors
4.1.6 Fusion Inhibitors
4.1.7 Entry Inhibitors - CCR5 Co-Receptor Antagonist
4.1.8 HIV Integrase Strand Transfer Inhibitors
4.2 By Type - Global HIV Drugs Revenue & Forecasts
4.2.1 By Type - Global HIV Drugs Revenue, 2018-2023
4.2.2 By Type - Global HIV Drugs Revenue, 2024-2029
4.2.3 By Type - Global HIV Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global HIV Drugs Sales & Forecasts
4.3.1 By Type - Global HIV Drugs Sales, 2018-2023
4.3.2 By Type - Global HIV Drugs Sales, 2024-2029
4.3.3 By Type - Global HIV Drugs Sales Market Share, 2018-2029
4.4 By Type - Global HIV Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HIV Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global HIV Drugs Revenue & Forecasts
5.2.1 By Application - Global HIV Drugs Revenue, 2018-2023
5.2.2 By Application - Global HIV Drugs Revenue, 2024-2029
5.2.3 By Application - Global HIV Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global HIV Drugs Sales & Forecasts
5.3.1 By Application - Global HIV Drugs Sales, 2018-2023
5.3.2 By Application - Global HIV Drugs Sales, 2024-2029
5.3.3 By Application - Global HIV Drugs Sales Market Share, 2018-2029
5.4 By Application - Global HIV Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global HIV Drugs Market Size, 2022 & 2029
6.2 By Region - Global HIV Drugs Revenue & Forecasts
6.2.1 By Region - Global HIV Drugs Revenue, 2018-2023
6.2.2 By Region - Global HIV Drugs Revenue, 2024-2029
6.2.3 By Region - Global HIV Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global HIV Drugs Sales & Forecasts
6.3.1 By Region - Global HIV Drugs Sales, 2018-2023
6.3.2 By Region - Global HIV Drugs Sales, 2024-2029
6.3.3 By Region - Global HIV Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America HIV Drugs Revenue, 2018-2029
6.4.2 By Country - North America HIV Drugs Sales, 2018-2029
6.4.3 US HIV Drugs Market Size, 2018-2029
6.4.4 Canada HIV Drugs Market Size, 2018-2029
6.4.5 Mexico HIV Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe HIV Drugs Revenue, 2018-2029
6.5.2 By Country - Europe HIV Drugs Sales, 2018-2029
6.5.3 Germany HIV Drugs Market Size, 2018-2029
6.5.4 France HIV Drugs Market Size, 2018-2029
6.5.5 U.K. HIV Drugs Market Size, 2018-2029
6.5.6 Italy HIV Drugs Market Size, 2018-2029
6.5.7 Russia HIV Drugs Market Size, 2018-2029
6.5.8 Nordic Countries HIV Drugs Market Size, 2018-2029
6.5.9 Benelux HIV Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia HIV Drugs Revenue, 2018-2029
6.6.2 By Region - Asia HIV Drugs Sales, 2018-2029
6.6.3 China HIV Drugs Market Size, 2018-2029
6.6.4 Japan HIV Drugs Market Size, 2018-2029
6.6.5 South Korea HIV Drugs Market Size, 2018-2029
6.6.6 Southeast Asia HIV Drugs Market Size, 2018-2029
6.6.7 India HIV Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America HIV Drugs Revenue, 2018-2029
6.7.2 By Country - South America HIV Drugs Sales, 2018-2029
6.7.3 Brazil HIV Drugs Market Size, 2018-2029
6.7.4 Argentina HIV Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa HIV Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa HIV Drugs Sales, 2018-2029
6.8.3 Turkey HIV Drugs Market Size, 2018-2029
6.8.4 Israel HIV Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia HIV Drugs Market Size, 2018-2029
6.8.6 UAE HIV Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb HIV Drugs Major Product Offerings
7.1.4 Bristol-Myers Squibb HIV Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences HIV Drugs Major Product Offerings
7.2.4 Gilead Sciences HIV Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline HIV Drugs Major Product Offerings
7.3.4 GlaxoSmithKline HIV Drugs Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson HIV Drugs Major Product Offerings
7.4.4 Johnson & Johnson HIV Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck HIV Drugs Major Product Offerings
7.5.4 Merck HIV Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
8 Global HIV Drugs Production Capacity, Analysis
8.1 Global HIV Drugs Production Capacity, 2018-2029
8.2 HIV Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global HIV Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HIV Drugs Supply Chain Analysis
10.1 HIV Drugs Industry Value Chain
10.2 HIV Drugs Upstream Market
10.3 HIV Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 HIV Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of HIV Drugs in Global Market
Table 2. Top HIV Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global HIV Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global HIV Drugs Revenue Share by Companies, 2018-2023
Table 5. Global HIV Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global HIV Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers HIV Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers HIV Drugs Product Type
Table 9. List of Global Tier 1 HIV Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global HIV Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global HIV Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global HIV Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global HIV Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global HIV Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global HIV Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global HIV Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global HIV Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global HIV Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global HIV Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global HIV Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global HIV Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global HIV Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global HIV Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global HIV Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America HIV Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America HIV Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America HIV Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe HIV Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe HIV Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe HIV Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia HIV Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia HIV Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia HIV Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America HIV Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America HIV Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America HIV Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa HIV Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa HIV Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa HIV Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa HIV Drugs Sales, (K Units), 2024-2029
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb HIV Drugs Product Offerings
Table 48. Bristol-Myers Squibb HIV Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences HIV Drugs Product Offerings
Table 52. Gilead Sciences HIV Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline HIV Drugs Product Offerings
Table 56. GlaxoSmithKline HIV Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson HIV Drugs Product Offerings
Table 60. Johnson & Johnson HIV Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck HIV Drugs Product Offerings
Table 64. Merck HIV Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. HIV Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global HIV Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global HIV Drugs Production by Region, 2018-2023 (K Units)
Table 69. Global HIV Drugs Production by Region, 2024-2029 (K Units)
Table 70. HIV Drugs Market Opportunities & Trends in Global Market
Table 71. HIV Drugs Market Drivers in Global Market
Table 72. HIV Drugs Market Restraints in Global Market
Table 73. HIV Drugs Raw Materials
Table 74. HIV Drugs Raw Materials Suppliers in Global Market
Table 75. Typical HIV Drugs Downstream
Table 76. HIV Drugs Downstream Clients in Global Market
Table 77. HIV Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. HIV Drugs Segment by Type in 2022
Figure 2. HIV Drugs Segment by Application in 2022
Figure 3. Global HIV Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global HIV Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global HIV Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. HIV Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by HIV Drugs Revenue in 2022
Figure 9. By Type - Global HIV Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global HIV Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global HIV Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global HIV Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global HIV Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global HIV Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global HIV Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global HIV Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global HIV Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global HIV Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global HIV Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global HIV Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America HIV Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America HIV Drugs Sales Market Share, 2018-2029
Figure 23. US HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe HIV Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe HIV Drugs Sales Market Share, 2018-2029
Figure 28. Germany HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia HIV Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia HIV Drugs Sales Market Share, 2018-2029
Figure 37. China HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America HIV Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America HIV Drugs Sales Market Share, 2018-2029
Figure 44. Brazil HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa HIV Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa HIV Drugs Sales Market Share, 2018-2029
Figure 48. Turkey HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE HIV Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global HIV Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production HIV Drugs by Region, 2022 VS 2029
Figure 54. HIV Drugs Industry Value Chain
Figure 55. Marketing Channels
